Drug profile · INN
bromocriptine mesylate
BROMOCRIPTINE MESYLATE
bromocriptine mesylate (BROMOCRIPTINE MESYLATE) is a d2-like dopamine receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — bromocriptine mesylate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
bromocriptine mesylate (BROMOCRIPTINE MESYLATE) is a d2-like dopamine receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
D2-like dopamine receptor agonist
Primary target: D2-like dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is bromocriptine mesylate?
bromocriptine mesylate (BROMOCRIPTINE MESYLATE) is a d2-like dopamine receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for bromocriptine mesylate?
BROMOCRIPTINE MESYLATE is a marketed brand name for bromocriptine mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bromocriptine mesylate?
bromocriptine mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.